BiotechTube
Home/Antev/Jens Bukrinski
JB

Jens Bukrinski

Head of CMC

Antev

Therapeutic Areas

OncologyUrologyMen's Health

Antev Pipeline

DrugIndicationPhase
TeverelixProstate Cancer (High CV Risk Patients)Phase 2

Leadership Team at Antev

AK
Amit Kohli
Chief Executive Officer
SV
Steve Van Os
Chief Medical Officer
CM
Carol MacLean
VP of Clinical Operations
PM
Paul Marchetto
Co Chairman of the Board
FM
Faisal Mehmud
Co Chairman of the Board
View full Antev profile